APA (7th ed.) Citation

FCA, d. M., ALS, d. O. R., E, P., JF, C., JWL, C., & RMR, B. (2025). Ethnic disparities in survival and progression among EGFR-mutated adenocarcinoma of lung cancer patients treated with tyrosine kinase inhibitors: A systematic review and meta-analysis. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 27(7), 3001. https://doi.org/10.1007/s12094-024-03843-4

Chicago Style (17th ed.) Citation

FCA, de Moraes, de Oliveira Rodrigues ALS, Pasqualotto E, Cassemiro JF, Choque JWL, and Burbano RMR. "Ethnic Disparities in Survival and Progression Among EGFR-mutated Adenocarcinoma of Lung Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review and Meta-analysis." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 27, no. 7 (2025): 3001. https://doi.org/10.1007/s12094-024-03843-4.

MLA (9th ed.) Citation

FCA, de Moraes, et al. "Ethnic Disparities in Survival and Progression Among EGFR-mutated Adenocarcinoma of Lung Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review and Meta-analysis." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 27, no. 7, 2025, p. 3001, https://doi.org/10.1007/s12094-024-03843-4.